Insider Trading Alert - SNI, TPC And GNMK Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, June 5, 2015, 80 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $368.50 to $15,580,000.00.

Highlighted Stocks Traded by Insiders:

Scripps Networks Interactive (SNI) - FREE Research Report

Logan Elizabeth A, who is 10% Owner at Scripps Networks Interactive, sold 96,416 shares at $72.29 on June 5, 2015. Following this transaction, the 10% Owner owned 22,993 shares meaning that the stake was reduced by 80.74% with the 96,416-share transaction.

The shares most recently traded at $67.91, down $4.38, or 6.46% since the insider transaction. Historical insider transactions for Scripps Networks Interactive go as follows:

  • 4-Week # shares bought: 15,000
  • 4-Week # shares sold: 2.5 million
  • 12-Week # shares bought: 15,000
  • 12-Week # shares sold: 2.5 million
  • 24-Week # shares bought: 804,000
  • 24-Week # shares sold: 3.5 million

The average volume for Scripps Networks Interactive has been 1.2 million shares per day over the past 30 days. Scripps Networks Interactive has a market cap of $6.4 billion and is part of the services sector and media industry. Shares are down 8.69% year-to-date as of the close of trading on Friday.

Scripps Networks Interactive, Inc. develops lifestyle-oriented content for linear and interactive video platforms in the United States, the United Kingdom and other European markets, the Middle East and Africa, the Asia-Pacific, and Latin America. The stock currently has a dividend yield of 1.36%. Currently, there are 4 analysts who rate Scripps Networks Interactive a buy, 2 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SNI - FREE

TheStreet Quant Ratings rates Scripps Networks Interactive as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, reasonable valuation levels and good cash flow from operations. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Scripps Networks Interactive Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Tutor Perini (TPC) - FREE Research Report

Ronald N. Tutor Separate Property Trust, who is 10% Owner at Tutor Perini, bought 95,004 shares at $22.52 on June 5, 2015. Following this transaction, the 10% Owner owned 5.8 million shares meaning that the stake was boosted by 1.68% with the 95,004-share transaction.

The shares most recently traded at $22.96, up $0.44, or 1.9% since the insider transaction. Historical insider transactions for Tutor Perini go as follows:

  • 4-Week # shares bought: 58,111
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 58,111
  • 12-Week # shares sold: 28,675
  • 24-Week # shares bought: 58,111
  • 24-Week # shares sold: 28,675

The average volume for Tutor Perini has been 227,300 shares per day over the past 30 days. Tutor Perini has a market cap of $1.1 billion and is part of the industrial goods sector and materials & construction industry. Shares are down 5.19% year-to-date as of the close of trading on Friday.

Tutor Perini Corporation provides diversified general contracting, construction management, and design-build services to private customers and public agencies worldwide. It operates in three segments: Civil, Building, and Specialty Contractors. The company has a P/E ratio of 11.2. Currently, there are 5 analysts who rate Tutor Perini a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TPC - FREE

TheStreet Quant Ratings rates Tutor Perini as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, poor profit margins and a generally disappointing performance in the stock itself. Get the full Tutor Perini Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

GenMark Diagnostics (GNMK) - FREE Research Report

Hawkins Jeffrey Alan, who is SVP, Global Marketing & PM at GenMark Diagnostics, sold 1,251 shares at $9.58 on June 5, 2015. Following this transaction, the SVP, Global Marketing & PM owned 116,878 shares meaning that the stake was reduced by 1.06% with the 1,251-share transaction.

Williams Jennifer Anne, who is SVP, Human Resources at GenMark Diagnostics, sold 1,678 shares at $9.59 on June 5, 2015. Following this transaction, the SVP, Human Resources owned 153,482 shares meaning that the stake was reduced by 1.08% with the 1,678-share transaction.

Gleeson Michael, who is SVP, North American Com. Ops. at GenMark Diagnostics, sold 1,595 shares at $9.55 on June 5, 2015. Following this transaction, the SVP, North American Com. Ops. owned 182,870 shares meaning that the stake was reduced by 0.86% with the 1,595-share transaction.

Chakravarty Ingo, who is SVP, International at GenMark Diagnostics, sold 183 shares at $9.81 on June 5, 2015. Following this transaction, the SVP, International owned 62,077 shares meaning that the stake was reduced by 0.29% with the 183-share transaction.

Stier Eric, who is SVP & General Counsel at GenMark Diagnostics, sold 292 shares at $9.91 on June 5, 2015. Following this transaction, the SVP & General Counsel owned 40,986 shares meaning that the stake was reduced by 0.71% with the 292-share transaction.

The shares most recently traded at $9.54, down $0.37, or 3.88% since the insider transaction. Historical insider transactions for GenMark Diagnostics go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 583
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 6,525
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 114,577

The average volume for GenMark Diagnostics has been 208,300 shares per day over the past 30 days. GenMark Diagnostics has a market cap of $414.6 million and is part of the health care sector and health services industry. Shares are down 27.7% year-to-date as of the close of trading on Friday.

GenMark Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, sells, and supports instruments and molecular tests based on its proprietary eSensor detection technology in the United States. Currently, there are 5 analysts who rate GenMark Diagnostics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GNMK - FREE

TheStreet Quant Ratings rates GenMark Diagnostics as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full GenMark Diagnostics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Podcast: What TheStreet's Interns Learned From Jim Cramer and Action Alerts PLUS

Podcast: What TheStreet's Interns Learned From Jim Cramer and Action Alerts PLUS

Bank of America, Tariffs and the Goldman Sachs CEO Change: Jim Cramer Rewind

Bank of America, Tariffs and the Goldman Sachs CEO Change: Jim Cramer Rewind

Here's Why Alphabet, Facebook and Amazon Earnings May Overshadow Tariff Worries

Here's Why Alphabet, Facebook and Amazon Earnings May Overshadow Tariff Worries

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

Don't Panic! The Risk of a Recession This Year Is Low

Don't Panic! The Risk of a Recession This Year Is Low